Skip to main content

Margaret Daley

Institution
University of Washington

Projects

NMR Structural Investigations of BRCA1

Lead Institution
University of Washington
Principal Investigator
Rachel Klevit
Project type
Capability Research
The breast and ovarian cancer tumor suppressor protein, BRCA1, supports a number of fundamental cellular processes. Its absence during embryogenesis is lethal. Loss of function in proliferating…

NMR Structural Investigations of BRCA1

Lead Institution
University of Washington
Principal Investigator
Rachel Klevit
Project type
Capability Research
The breast and ovarian cancer tumor suppressor protein, BRCA1, supports a number of fundamental cellular processes. Its absence during embryogenesis is lethal. Loss of function in proliferating…

NMR Structural Investigations of BRCA1

Lead Institution
University of Washington
Principal Investigator
Rachel Klevit
Project type
Capability Research
The breast and ovarian cancer tumor suppressor protein, BRCA1, supports a number of fundamental cellular processes. Its absence during embryogenesis is lethal. Loss of function in proliferating…

NMR Structural Investigations of BRCA1

Lead Institution
University of Washington
Principal Investigator
Rachel Klevit
Project type
Capability Research
The breast and ovarian cancer tumor suppressor protein, BRCA1, supports a number of fundamental cellular processes. Its absence during embryogenesis is lethal. Loss of function in proliferating…

NMR Structural Investigations of BRCA1

Lead Institution
University of Washington
Principal Investigator
Rachel Klevit
Project type
Capability Research
The breast and ovarian cancer tumor suppressor protein, BRCA1, supports a number of fundamental cellular processes. Its absence during embryogenesis is lethal. Loss of function in proliferating…

NMR Structural Investigations of BRCA1

Lead Institution
University of Washington
Principal Investigator
Rachel Klevit
Project type
Capability Research
Recent identification of the breast and ovarian cancer susceptibility gene, BRCA1, promises to generate a wealth of information concerning breast and ovarian cancer cell biology.